422 related articles for article (PubMed ID: 30883699)
1. Impact of resection margin status on recurrence and survival in pancreatic cancer surgery.
Tummers WS; Groen JV; Sibinga Mulder BG; Farina-Sarasqueta A; Morreau J; Putter H; van de Velde CJ; Vahrmeijer AL; Bonsing BA; Mieog JS; Swijnenburg RJ
Br J Surg; 2019 Jul; 106(8):1055-1065. PubMed ID: 30883699
[TBL] [Abstract][Full Text] [Related]
2. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
Hank T; Hinz U; Tarantino I; Kaiser J; Niesen W; Bergmann F; Hackert T; Büchler MW; Strobel O
Br J Surg; 2018 Aug; 105(9):1171-1181. PubMed ID: 29738626
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma.
Ghaneh P; Kleeff J; Halloran CM; Raraty M; Jackson R; Melling J; Jones O; Palmer DH; Cox TF; Smith CJ; O'Reilly DA; Izbicki JR; Scarfe AG; Valle JW; McDonald AC; Carter R; Tebbutt NC; Goldstein D; Padbury R; Shannon J; Dervenis C; Glimelius B; Deakin M; Anthoney A; Lerch MM; Mayerle J; Oláh A; Rawcliffe CL; Campbell F; Strobel O; Büchler MW; Neoptolemos JP;
Ann Surg; 2019 Mar; 269(3):520-529. PubMed ID: 29068800
[TBL] [Abstract][Full Text] [Related]
4. Effect of resection margin status on recurrence pattern and survival in distal pancreatectomy for left-sided pancreatic ductal adenocarcinoma.
Kwon J; Lee SR; Park SY; Lee JH; Song KB; Hwang DW; Shin JH; Kim SC
J Hepatobiliary Pancreat Sci; 2023 May; 30(5):633-643. PubMed ID: 36380718
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of margin status on survival and recurrence pattern after curative-intent surgery for pancreatic cancer.
Yamamoto T; Uchida Y; Terajima H
Asian J Surg; 2019 Jan; 42(1):93-99. PubMed ID: 29249392
[TBL] [Abstract][Full Text] [Related]
6. Utility of the proximal margin frozen section for resection of gastric adenocarcinoma: a 7-Institution Study of the US Gastric Cancer Collaborative.
Squires MH; Kooby DA; Pawlik TM; Weber SM; Poultsides G; Schmidt C; Votanopoulos K; Fields RC; Ejaz A; Acher AW; Worhunsky DJ; Saunders N; Jin LX; Levine E; Cho CS; Bloomston M; Winslow E; Cardona K; Staley CA; Maithel SK
Ann Surg Oncol; 2014 Dec; 21(13):4202-10. PubMed ID: 25047464
[TBL] [Abstract][Full Text] [Related]
7. R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic Cancer.
Demir IE; Jäger C; Schlitter AM; Konukiewitz B; Stecher L; Schorn S; Tieftrunk E; Scheufele F; Calavrezos L; Schirren R; Esposito I; Weichert W; Friess H; Ceyhan GO
Ann Surg; 2018 Dec; 268(6):1058-1068. PubMed ID: 28692477
[TBL] [Abstract][Full Text] [Related]
8. Prospective assessment of resection margin status following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma after standardisation of margin definitions.
Pine JK; Haugk B; Robinson SM; Darne A; Wilson C; Sen G; French JJ; White SA; Manas DM; Charnley RM
Pancreatology; 2020 Apr; 20(3):537-544. PubMed ID: 31996296
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
[TBL] [Abstract][Full Text] [Related]
10. Impact of resection margin status on survival in advanced N stage pancreatic cancer - a multi-institutional analysis.
Teske C; Stimpel R; Distler M; Merkel S; Grützmann R; Bolm L; Wellner U; Keck T; Aust DE; Weitz J; Welsch T
Langenbecks Arch Surg; 2021 Aug; 406(5):1481-1489. PubMed ID: 33712875
[TBL] [Abstract][Full Text] [Related]
11. Margin status, recurrence pattern, and prognosis after resection of pancreatic cancer.
Sugiura T; Uesaka K; Mihara K; Sasaki K; Kanemoto H; Mizuno T; Okamura Y
Surgery; 2013 Nov; 154(5):1078-86. PubMed ID: 23973112
[TBL] [Abstract][Full Text] [Related]
12. Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group.
Zhang XF; Wu Z; Cloyd J; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Schmidt CR; Dillhoff M; Maithel SK; Pawlik TM
Surgery; 2019 Mar; 165(3):548-556. PubMed ID: 30278986
[TBL] [Abstract][Full Text] [Related]
13. The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Nitta T; Nakamura T; Mitsuhashi T; Asano T; Okamura K; Tsuchikawa T; Tamoto E; Murakami S; Noji T; Kurashima Y; Ebihara Y; Nakanishi Y; Shichinohe T; Hirano S
Surg Today; 2017 Apr; 47(4):490-497. PubMed ID: 27677294
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic Cancer Surgery: The New R-status Counts.
Strobel O; Hank T; Hinz U; Bergmann F; Schneider L; Springfeld C; Jäger D; Schirmacher P; Hackert T; Büchler MW
Ann Surg; 2017 Mar; 265(3):565-573. PubMed ID: 27918310
[TBL] [Abstract][Full Text] [Related]
15. Microscopic resection margin status in pancreatic ductal adenocarcinoma - A nationwide analysis.
Daamen LA; van Goor IWJM; Schouten TJ; Dorland G; van Roessel SR; Besselink MG; Bonsing BA; Bosscha K; Brosens LAA; Busch OR; van Dam RM; Fariña Sarasqueta A; Festen S; Groot Koerkamp B; van der Harst E; de Hingh IHJT; Intven MPW; Kazemier G; de Meijer VE; Nieuwenhuijs VB; Raicu GM; Roos D; Schreinemakers JMJ; Stommel MWJ; van Velthuysen MF; Verheij J; Verkooijen HM; van Santvoort HC; Molenaar IQ;
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):708-716. PubMed ID: 33323293
[TBL] [Abstract][Full Text] [Related]
16. Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients.
Kooby DA; Lad NL; Squires MH; Maithel SK; Sarmiento JM; Staley CA; Adsay NV; El-Rayes BF; Weber SM; Winslow ER; Cho CS; Zavala KA; Bentrem DJ; Knab M; Ahmad SA; Abbott DE; Sutton JM; Kim HJ; Yeh JJ; Aufforth R; Scoggins CR; Martin RC; Parikh AA; Robinson J; Hashim YM; Fields RC; Hawkins WG; Merchant NB
Ann Surg; 2014 Sep; 260(3):494-501; discussion 501-3. PubMed ID: 25115425
[TBL] [Abstract][Full Text] [Related]
17. R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma.
Crippa S; Giannone F; Schiavo Lena M; Belfiori G; Partelli S; Tamburrino D; Delpini R; Pagnanelli M; Pecorelli N; Balzano G; Doglioni C; Falconi M
Ann Surg Oncol; 2021 Aug; 28(8):4602-4612. PubMed ID: 33393031
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of radical resection rates and margin assessment in pancreatic cancer.
Chandrasegaram MD; Goldstein D; Simes J; Gebski V; Kench JG; Gill AJ; Samra JS; Merrett ND; Richardson AJ; Barbour AP
Br J Surg; 2015 Nov; 102(12):1459-72. PubMed ID: 26350029
[TBL] [Abstract][Full Text] [Related]
19. Impact of Neoadjuvant Therapy on Survival Following Margin-Positive Resection for Pancreatic Cancer.
Chopra A; Zenati M; Hogg ME; Zeh HJ; Bartlett DL; Bahary N; Zureikat AH; Beane JD
Ann Surg Oncol; 2021 Nov; 28(12):7759-7769. PubMed ID: 34027585
[TBL] [Abstract][Full Text] [Related]
20. Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma.
Jamiyan T; Shiraki T; Kurata Y; Ichinose M; Kubota K; Imai Y
World J Surg Oncol; 2020 Jun; 18(1):137. PubMed ID: 32571348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
